MRTX-1719
MRTX-1719
CAS: 2630904-45-7
Molecular Formula: C23H18ClFN6O2
MRTX-1719 - Names and Identifiers
| Name | MRTX-1719 |
| Synonyms | MRTX-1719 Benzonitrile, 2-[4-[4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl]-1-methyl-1H-pyrazol-5-yl]-4-chloro-6-(cyclopropyloxy)-3-fluoro-, (2R)- |
| CAS | 2630904-45-7 |
MRTX-1719 - Physico-chemical Properties
| Molecular Formula | C23H18ClFN6O2 |
| Molar Mass | 464.89 |
MRTX-1719 - Introduction
MRTX-1719 is a chemical, it is a small molecule anti-tumor drug. The compound is widely studied and developed as a KRAS gene mutation inhibitor for the treatment of tumors with KRAS mutations.
MRTX-1719 are mainly used to treat cancers caused by KRAS mutations, such as lung cancer and colorectal cancer. KRAS mutations are widespread in many cancers, but effective treatments targeting this mutation have long been difficult. MRTX-1719 development aims to provide a new treatment for KRAS mutations.
Regarding the production method, the specific synthesis method of the MRTX-1719 has not been disclosed. In general, the preparation of such drugs involves complex processes of organic synthesis and medicinal chemistry.
In terms of safety, MRTX-1719 is still in the development stage and has not been approved for marketing by the U.S. Food and Drug Administration (FDA) or other regulatory agencies. Therefore, detailed safety information about this substance has not been made public. However, in clinical trials, the safety of drugs has been an important concern. Researchers will conduct a rigorous evaluation of potential adverse reactions and side effects and work to ensure that the drug is safe and reliable for use.
MRTX-1719 are mainly used to treat cancers caused by KRAS mutations, such as lung cancer and colorectal cancer. KRAS mutations are widespread in many cancers, but effective treatments targeting this mutation have long been difficult. MRTX-1719 development aims to provide a new treatment for KRAS mutations.
Regarding the production method, the specific synthesis method of the MRTX-1719 has not been disclosed. In general, the preparation of such drugs involves complex processes of organic synthesis and medicinal chemistry.
In terms of safety, MRTX-1719 is still in the development stage and has not been approved for marketing by the U.S. Food and Drug Administration (FDA) or other regulatory agencies. Therefore, detailed safety information about this substance has not been made public. However, in clinical trials, the safety of drugs has been an important concern. Researchers will conduct a rigorous evaluation of potential adverse reactions and side effects and work to ensure that the drug is safe and reliable for use.
Last Update：2024-04-09 21:49:45
Supplier List
Spot supply
Product Name: (2R)-2-(4-(4-(Aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile Request for quotationCAS: 2630904-45-7
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365
Wechat: 18916960931
Spot supply
Product Name: 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Spot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Multiple SpecificationsSpot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +16314854226
Email: info@bocsci.com
Mobile: +16314854226
Linkedin: https://www.linkedin.com/company/boc-sciences
Product List: View Catalog
Spot supply
Product Name: (2R)-2-(4-(4-(Aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile Request for quotationCAS: 2630904-45-7
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365
Wechat: 18916960931
Spot supply
Product Name: 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Spot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Multiple SpecificationsSpot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: MRTX-1719 Visit Supplier Webpage Request for quotationCAS: 2630904-45-7
Tel: +16314854226
Email: info@bocsci.com
Mobile: +16314854226
Linkedin: https://www.linkedin.com/company/boc-sciences
Product List: View Catalog
View History
MRTX-1719
M-[DIMETHYLAMINO]ANILINE DIHYDROCHLORIDE
nickel(2+) ion tungstate
91469-69-1
1258638-92-4
SALOR-INT L308641-1EA
123470-94-0
sodiumcoumadin
苯开普顿
正己烷中异丙草胺标准品
M-[DIMETHYLAMINO]ANILINE DIHYDROCHLORIDE
nickel(2+) ion tungstate
91469-69-1
1258638-92-4
SALOR-INT L308641-1EA
123470-94-0
sodiumcoumadin
苯开普顿
正己烷中异丙草胺标准品